Home » Newsletters » BioWorld Science

BioWorld Science

June 16, 2010

View Archived Issues

NeuroSearch claims new K(V)7 potassium channel activators

Novel autotaxin inhibitors identified by Merck KGaA

Alla Chem discloses new antiviral agents

Boehringer Ingelheim discovers new 5-HT2C receptor agonists

Mikana Therapeutics presents new protein kinase inhibitors

Long-term treatment compliance seen with Grazax vaccine tablet

JNJ-37822681 is safe and shows good D2 receptor occupancy in healthy men

BPA-directed antibody level in serum shows promise as biomarker for melanoma

Safety and preliminary antitumor activity of OSI-027 seen in ongoing first-in-man trial

Interim phase II data disclosed on PF-00299804 in recurrent/metastatic SCCHN

Novo Nordisk reports highlights of first quarter 2010

CF-102 shows anti-inflammatory and antitumor activity in vitro

Deferiprone reduces brain iron but does not lead to clinical improvement in PKAN

ViroStatics and Vichem Chemie collaborate on AV-HALTs for HIV/AIDS

Chiasma reports on phase I trial of oral octreotide acetate

FDA clears phase I/II alpha-1-antitrypsin trial in type 1 diabetes

PPD and Furiex complete spin-off of Furiex

Takeda launches Nesina, Unisia and Vectibix in Japan

Lundbeck to use Orasi Index to test effects of CNS drugs on human brain

EMA's COMP recommends orphan status for DR Cysteamine in cystinosis

Celsion to report on phase I/II DIGNITY trial in recurrent chest wall breast cancer

Amylin, Lilly and Alkermes report on DURATION-4 trial of Bydureon

Scancell begins dosing in phase I trial of SCIB-1 in melanoma

Stealth Peptides' phase I Bendavia trial progresses

COMP recommends orphan drug status for 2B3-101 in glioma

Otonomy secures funds to advance OTO-104 and OTO-203

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...